A ten-tablet blister of clomiphene citrate at 50 mg, made by Cipla, a large publicly listed Indian pharmaceutical company whose ordinary business is mainstream prescription medicine rather than products aimed at this market.
That origin is the real difference between this box and lab-branded clomiphene: identical molecule, retail-pharmacy presentation, small count. The compound modulates estrogen receptors at the pituitary and hypothalamus, which lifts LH and FSH signalling, and 50 mg has been the standard tablet strength for the drug for decades.
